Evidence map›Paper›PMID 23115302›Full record

ArticleMolecular & cellular proteomics : MCP2013

A combined laser microdissection and mass spectrometry approach reveals new disease relevant proteins accumulating in aggregates of filaminopathy patients.

Rudolf A Kley, Alexandra Maerkens, Yvonne Leber, Verena Theis, Anja Schreiner, Peter F M van der Ven, Julian Uszkoreit, Christian Stephan, Stefan Eulitz, Nicole Euler and 8 more

Open access · hybridAbstract read
In one paragraph

Article in Molecular & cellular proteomics : MCP, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 46 papers.

0numbers the graph read from it
0cells of the map it votes in
46citing papers in PubMed
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

46 citing papers in PubMed, 85 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Caenorhabditis elegans small heat-shock protein HSP-12.6 has a highly specialized protective function towards muscle thick filaments in vivo.Philosophical transactions of the Royal Society of London. Series B, Biological sciences · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 5 institutions in 2 countries.

Rudolf A KleyDepartment of Neurology, Neuromuscular Center Ruhrgebiet, University Hospital Bergmannsheil, Ruhr-University Bochum, Germany.
Alexandra Maerkens
Yvonne Leber
Verena Theis
Anja Schreiner
Peter F M van der Ven
Julian Uszkoreit
Christian Stephan
Stefan Eulitz
Nicole Euler
Janbernd Kirschner
Klaus Müller
Helmut E Meyer
Martin Tegenthoff
Dieter O Fürst
Matthias Vorgerd
Thorsten Müller
Katrin Marcus
Ruhr University Bochum · DEUniversity of Bonn · DEBG University Hospital Bergmannsheil Bochum · DEBoston Children's Hospital · USGoethe University Frankfurt · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Filaminopathy is a subtype of myofibrillar myopathy caused by mutations in FLNC, the gene encoding filamin C, and histologically characterized by pathologic accumulation of several proteins within skeletal muscle fibers. With the aim to get new insights in aggregate composition, we collected aggregates and control tissue from skeletal muscle biopsies of six myofibrillar myopathy patients harboring three different FLNC mutations by laser microdissection and analyzed the samples by a label-free mass spectrometry approach. A total of 390 proteins were identified, and 31 of those showed significantly higher spectral indices in aggregates compared with patient controls with a ratio >1.8. These proteins included filamin C, other known myofibrillar myopathy associated proteins, and a striking number of filamin C binding partners. Across the patients the patterns were extremely homogeneous. Xin actin-binding repeat containing protein 2, heat shock protein 27, nebulin-related-anchoring protein, and Rab35 could be verified as new filaminopathy biomarker candidates. In addition, further experiments identified heat shock protein 27 and Xin actin-binding repeat containing protein 2 as novel filamin C interaction partners and we could show that Xin actin-binding repeat containing protein 2 and the known interaction partner Xin actin-binding repeat containing protein 1 simultaneously associate with filamin C. Ten proteins showed significant lower spectral indices in aggregate samples compared with patient controls (ratio <0.56) including M-band proteins myomesin-1 and myomesin-2. Proteomic findings were consistent with previous and novel immunolocalization data. Our findings suggest that aggregates in filaminopathy have a largely organized structure of proteins also interacting under physiological conditions. Different filamin C mutations seem to lead to almost identical aggregate compositions. The finding that filamin C was detected as highly abundant protein in aggregates in filaminopathy indicates that our proteomic approach may be suitable to identify new candidate genes among the many MFM patients with so far unknown mutation.

Indexed as

AdultBiomarkers, TumorContractile ProteinsDNA-Binding ProteinsFemaleFilaminsHeat-Shock ProteinsHSP27 Heat-Shock ProteinsHumansLIM Domain ProteinsMaleMass SpectrometryMicrofilament ProteinsMiddle AgedMolecular ChaperonesMuscle Fibers, SkeletalBiomarkers, TumorContractile ProteinsDNA-Binding ProteinsFilaminsFLNC protein, humanHeat-Shock ProteinsHSP27 Heat-Shock ProteinsHSPB1 protein, humanLIM Domain ProteinsMicrofilament ProteinsMolecular ChaperonesMuscle ProteinsNRAP protein, humanNuclear ProteinsProteomeRAB35 protein, humanrab GTP-Binding ProteinsXIRP2 protein, human

Identifiers

PMID23115302
PMCPMC3536902
OpenAlexW2096784372

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.